Amoxicillin As Trihydrate; Clavulanate Potassium ( K-Clavulanate)

Verify with FDA CVM →

271 adverse event reports submitted to the FDA

Important: Adverse event reports do not establish that a drug caused or contributed to the event. Consult your veterinarian before making treatment decisions.
271
Total Reports
19
Deaths Reported
700.0%
Death Rate

Active Ingredients

Amoxicillin As Trihydrate; Clavulanate Potassium ( K-Clavulanate)

Administration Routes

UnknownOralOphthalmic

Species Affected

Unknown 141
Dog 91
Cat 39

Most Affected Breeds

Unknown 141
Domestic Shorthair 19
Retriever - Labrador 14
Beagle 7
Terrier - Yorkshire 7
Cat (unknown) 6
Bichon Frise 5
Chihuahua 5
Siberian Husky 3
Persian 3

Most Reported Reactions

Color, Abnormal 134
Suspension, Abnormal 85
Uncoded sign 53
Lack of efficacy (bacteria) - NOS 34
Lethargy (see also Central nervous system depression in 'Neurological') 29
Vomiting 24
Anorexia 22
Other abnormal test result NOS 20
Diarrhoea 17
Lack of efficacy - NOS 12
Anaemia NOS 11
Death by euthanasia 10

Outcome Breakdown

Ongoing
69 (52.7%)
Recovered/Normal
24 (18.3%)
Outcome Unknown
19 (14.5%)
Euthanized
11 (8.4%)
Died
8 (6.1%)

Data Summary

Metric Value
Total adverse event reports 271
Reports involving death 19
Case-fatality rate (reported events) 700.0%
Distinct species in reports 3
Distinct breeds in reports 20
Distinct reactions reported 20
Active ingredients on file 1

Source: FDA Center for Veterinary Medicine — Adverse Event Reporting (CVM AER). Counts reflect voluntary reports only.

Amoxicillin As Trihydrate; Clavulanate Potassium ( K-Clavulanate) Adverse Event Insights

The FDA Center for Veterinary Medicine database currently holds 271 adverse event reports referencing Amoxicillin As Trihydrate; Clavulanate Potassium ( K-Clavulanate), including 19 reports in which the animal died — a 700.0% case-fatality figure among reported events only, not a population-level mortality rate. Active ingredient on file: Amoxicillin As Trihydrate; Clavulanate Potassium ( K-Clavulanate). Reported administration routes include Unknown, Oral, Ophthalmic. These numbers reflect voluntary submissions from pet owners, veterinarians, and manufacturers and therefore under-represent mild events and over-represent severe ones — a pattern the FDA has documented repeatedly for pharmacovigilance datasets.

The species most frequently named in Amoxicillin As Trihydrate; Clavulanate Potassium ( K-Clavulanate) reports are Unknown (141 reports), Dog (91 reports), Cat (39 reports), with Unknown accounting for the largest share. Within those species, Unknown (141), Domestic Shorthair (19), Retriever - Labrador (14) appear most often — though breed popularity and ownership density shape these counts as much as any drug-specific sensitivity. This distribution matters because the same active ingredient can behave very differently across body sizes, ages, and species physiology.

The most commonly reported clinical signs associated with Amoxicillin As Trihydrate; Clavulanate Potassium ( K-Clavulanate) are Color, Abnormal (134), Suspension, Abnormal (85), Uncoded sign (53), Lack of efficacy (bacteria) - NOS (34). Of the 131 reports with a coded outcome, Ongoing is the leading category at 52.7%. Because FDA adverse event data describes correlation rather than causation, these figures are best used to frame informed questions with a veterinarian and to compare reporting patterns across related products — not as a standalone safety verdict on Amoxicillin As Trihydrate; Clavulanate Potassium ( K-Clavulanate).

Source: FDA Center for Veterinary Medicine — Adverse Event Reports FDA Center for Veterinary Medicine — Adverse Event Reports Data reflects voluntary submissions and may not represent actual incidence rates

Related

Data sourced from official AKC, AVMA, ACVO, and breed-club veterinary references. See our methodology for details. Retrieved and formatted by PlainBreed Editorial